VMIC: A base for worldwide collaboration in the development of vaccines
Harwell VMIC: New vaccine centre sold to company - BBC News
Britain will be able to vaccinate nation against new Covid strains within months after new super-factory opens
Plans to sell off UK vaccine development centre criticised by scientists | Vaccines and immunisation | The Guardian
Delivering a billion doses with the UK VMIC - Pharma Technology Focus | Issue 103 | February 2021
Exterior Architecture completes its work at fast-tracked vaccines centre | News | Building Design
UK Covid-19 vaccine rollout: Daria Donati discusses the challenges ahead
Oxford vaccine and research centre worth £200m could be sold - BBC News
VMIC partners with Oxford Biomedica
Vaccines Manufacturing and Innovation Centre (VMIC) - News, Articles etc. - European Pharmaceutical Review
Vaccines Manufacturing and Innovation Centre expands team with 50 new jobs to focus on COVID-19 response and 2021 operational readiness | OxLEP
BES injects specialist expertise into VMIC vaccine facility fit-out
Government to invest £93m in UK vaccine manufacturing centre | Vaccines and immunisation | The Guardian
Vaccines Manufacturing Innovation Centre, Oxfordshire, UK
UK's rapid response vaccines manufacturing centre now approved – UKRI
Oxford vaccine and research centre worth £200m could be sold - BBC News
Harwell Campus forging ahead with five million sq.ft masterplan | OxLEP
Catalent, Oxfordshire - Former Vaccine Manufacturing & Innovation Centre ( VMIC) - Glencar Construction
Rally to stop the Vaccine Manufacturing Centre Sell Off! | We Own It
Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe - Catalent Biologics
Academic Medical | Tradeline, Inc.
Catalent acquires UK facility from VMIC
Vaccines Manufacturing and Innovation Centre Fast Tracked as Works Progress at Harwell Campus | OxLEP
